These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 2454947)

  • 1. Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models.
    Gigliotti F; Hughes WT
    J Clin Invest; 1988 Jun; 81(6):1666-8. PubMed ID: 2454947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and initial characterization of a ferret Pneumocystis carinii surface antigen.
    Gigliotti F; Ballou LR; Hughes WT; Mosley BD
    J Infect Dis; 1988 Oct; 158(4):848-54. PubMed ID: 3262695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of murine monoclonal antibodies to Pneumocystis carinii.
    Gigliotti F; Stokes DC; Cheatham AB; Davis DS; Hughes WT
    J Infect Dis; 1986 Aug; 154(2):315-22. PubMed ID: 3522758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to Pneumocystis carinii: identification of specific antigens and characterization of antigenic differences between rat and human isolates.
    Kovacs JA; Halpern JL; Lundgren B; Swan JC; Parrillo JE; Masur H
    J Infect Dis; 1989 Jan; 159(1):60-70. PubMed ID: 2642522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of antigens and antibodies specific for Pneumocystis carinii.
    Kovacs JA; Halpern JL; Swan JC; Moss J; Parrillo JE; Masur H
    J Immunol; 1988 Mar; 140(6):2023-31. PubMed ID: 3257995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with recombinant Pneumocystis carinii p55 antigen provides partial protection against infection: characterization of epitope recognition associated with immunization.
    Smulian AG; Sullivan DW; Theus SA
    Microbes Infect; 2000 Feb; 2(2):127-36. PubMed ID: 10742685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis carinii antigen detection in rat serum and lung lavage.
    McNabb SJ; Graves DC; Kosanke SD; Moyer MJ; Ivey MH
    J Clin Microbiol; 1988 Sep; 26(9):1763-71. PubMed ID: 3263387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of monoclonal antibody against Pneumocystis carinii by using a hybrid of rat spleen and mouse myeloma cells.
    Lee CH; Bolinger CD; Bartlett MS; Kohler RB; Wilde CE; Smith JW
    J Clin Microbiol; 1986 Mar; 23(3):505-8. PubMed ID: 3514660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Search for extrapulmonary Pneumocystis carinii in an animal model.
    Oz HS; Hughes WT; Vargas SL
    J Parasitol; 1996 Apr; 82(2):357-9. PubMed ID: 8604119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Pneumocystis carinii in lung-derived samples using monoclonal antibodies to an 82 kDa parasite component.
    Linder E; Lundin L; Vorma H
    J Immunol Methods; 1987 Apr; 98(1):57-62. PubMed ID: 2435811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein of Pneumocystis carinii confers protection in the rat.
    Theus SA; Andrews RP; Steele P; Walzer PD
    J Clin Invest; 1995 Jun; 95(6):2587-93. PubMed ID: 7769101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Pneumocystis carinii monoclonal antibodies.
    Bogucki MS; Fishman JA; Radding JA; Armstrong MY; Richards FF
    J Protozool; 1989; 36(1):41S-43S. PubMed ID: 2785192
    [No Abstract]   [Full Text] [Related]  

  • 13. Proliferation patterns of latent Pneumocystis carinii in rat organs during progressive stages of immunosuppression.
    Reddy LV; Zammit C
    J Protozool; 1991; 38(6):43S-47S. PubMed ID: 1824564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of a monoclonal antibody with specificity for the pellicle of Pneumocystis carinii by hybridoma.
    Matsumoto Y; Amagai T; Yamada M; Imanishi J; Yoshida Y
    Parasitol Res; 1987; 73(3):228-33. PubMed ID: 2438684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocytes in host defense against Pneumocystis carinii.
    Beck JM; Harmsen AG
    Semin Respir Infect; 1998 Dec; 13(4):330-8. PubMed ID: 9872630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural localization of epitopes recognized by monoclonal antibodies produced to rat Pneumocystis carinii.
    Yoshikawa H; Debault LE; Graves DC
    J Protozool; 1991; 38(6):18S-20S. PubMed ID: 1726325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic comparisons of Pneumocystis carinii strains obtained from rats, ferrets, and mice using convalescent sera from the same sources.
    Bauer NL; Paulsrud JR; Bartlett MS; Smith JW; Wilde CE
    J Protozool; 1991; 38(6):166S-168S. PubMed ID: 1818152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody to Pneumocystis carinii protects rats and mice from developing pneumonia.
    Bartlett MS; Angus WC; Shaw MM; Durant PJ; Lee CH; Pascale JM; Smith JW
    Clin Diagn Lab Immunol; 1998 Jan; 5(1):74-7. PubMed ID: 9455884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia.
    Gigliotti F; Haidaris CG; Wright TW; Harmsen AG
    Infect Immun; 2002 Mar; 70(3):1069-74. PubMed ID: 11854184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CD40 ligand and other immunomodulators on Pneumocystis carinii infection in rat model.
    Oz HS; Hughes WT; Rehg JE; Thomas EK
    Microb Pathog; 2000 Sep; 29(3):187-90. PubMed ID: 10968950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.